Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 36Leukemia 32Myelodysplastic Syndromes 29Leukemia, Myeloid, Acute 27Leukemia, Myelomonocytic, Chronic 23Congenital Abnormalities 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myeloproliferative Disorders 10Leukemia, Myelomonocytic, Acute 10Blast Crisis 10Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myeloid, Accelerated Phase 8Anemia, Refractory 8Myelodysplastic-Myeloproliferative Diseases 7Lymphoma 7Thrombocytopenia 6Leukemia, Myeloid, Chronic-Phase 6Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Leukemia, Lymphocytic, Chronic, B-Cell 5Primary Myelofibrosis 4Neoplasms, Plasma Cell 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Hodgkin Disease 4

Interventions

Cyclophosphamide 23fludarabine phosphate 19Whole-Body Irradiation 17fludarabine 16Melphalan 16Tacrolimus 14Busulfan 14Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Alemtuzumab 9Cyclosporine 7Methotrexate 6Antilymphocyte Serum 6thymoglobulin 4Stem Cell Transplantation 4Thiotepa 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3sargramostim 2Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × Cytarabine × Classical hematology × Clear all
NCT01500161 2013-11-25

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Texas Oncology Cancer Center

Phase 2 Terminated
1 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡